Overview

Effects of Ramelteon on Driving Ability

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to investigate the effects of bedtime administration of a single dose of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on next-morning on-road driving performance. In addition, the drugs' effects on balance are evaluated during the night, and the next morning residual effects on memory and psychomotor performance.
Phase:
Phase 1
Details
Lead Sponsor:
Utrecht Institute for Pharmaceutical Sciences
Collaborator:
Takeda
Treatments:
Zopiclone